Eukaryotic expression systems are frequently employed for the producti
on of recombinant proteins as therapeutics as well as research tools.
Most commonly used expression systems are based on stably transfected
adherent CHO cells or nonadherent lymphoid cell lines. An efficient al
ternative is the infection of insect cells by recombinant baculoviruse
s. Transient expression in mammalian cells, e.g., COS cells, is often
used for the production of smaller quantities of proteins. The choice
of a suitable expression system depends largely on the biochemical and
biological properties of the protein of interest, as well as on the n
ature of the planned experiments and the amount of recombinant protein
required. We summarize here the expression of the cytokine human Leuk
emia Inhibitory Factor (hu-LIF) in five of the most commonly used syst
ems, namely in CHO, Sp2/0, MEL, COS, and insect cells, in conjunction
with an outline of the principles and characteristics of each of these
expression systems. In result, the stably transfected cell lines, CHO
, Sp2/0, and MEL cells, gave rise to production of fully glycosylated
hu-LIF at variable product titers; incompletely glycosylated, albeit b
iological active hu-LIF could be rapidly produced by transient express
ion in COS cells or by baculovirus-mediated infection of insect cells.
(C) 1996 Academic Press, Inc.